Apogee Therapeutics (APGE) Interest & Investment Income (2023 - 2026)
Apogee Therapeutics' Interest & Investment Income was $11.81 million in Q2 2026, up 65.4% from $7.14 million a year earlier and up 35.1% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Apogee Therapeutics' Interest & Investment Income was $35.6 million through Jun 30, 2026, up 6.8% year-over-year; for FY2025, it came in at $30.03 million, down 13.6% from FY2024.
- Interest & Investment Income shows a three-year compound annual growth rate of 588.5% (FY2022 to FY2025).
- In earlier years, Interest & Investment Income was $34.74 million in FY2024 (+285.3%), $9.02 million in FY2023 and $92,000 in FY2022.
- The Q2 2026 figure marks the highest quarterly Interest & Investment Income in data going back to Q1 2023.
- Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 35.0% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2024 (growth of 179.0%); the worst was Q3 2025 (a decline of 34.7%).
- Per Business Quant data, APGE's Interest & Investment Income in the three quarters before Q2 2026 was $8.74 million (Q1 2026), $8.73 million (Q4 2025) and $6.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 11.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 8.74 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 9.67 Mn |
| Jun 30, 2024 | 10.31 Mn |
| Mar 31, 2024 | 6.09 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 133,000.00 |
API Access
Apogee Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();